Authors:
Kelner, MJ
McMorris, TC
Estes, LA
Oval, MY
Rojas, RJ
Lynn, JR
Lanham, KA
Samson, KM
Citation: Mj. Kelner et al., Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograft, ANTI-CANC D, 11(3), 2000, pp. 217-224
Authors:
Kelner, MJ
McMorris, TC
Estes, L
Samson, KM
Trani, NA
MacDonald, JR
Citation: Mj. Kelner et al., Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with topotecan, LEUKEMIA, 14(1), 2000, pp. 136-141
Citation: Tc. Mcmorris et al., Preparation and biological activity of amino acid and peptide conjugates of antitumor hydroxymethylacylfulvene, J MED CHEM, 43(19), 2000, pp. 3577-3580
Citation: Tc. Mcmorris, Discovery and development of sesquiterpenoid derived hydroxymethylacylfulvene: A new anticancer drug, BIO MED CH, 7(5), 1999, pp. 881-886
Authors:
Kelner, MJ
McMorris, TC
Montoya, MA
Estes, L
Uglik, SF
Rutherford, M
Samson, KM
Bagnell, RD
Taetle, R
Citation: Mj. Kelner et al., Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines, CANC CHEMOT, 44(3), 1999, pp. 235-240